113 related articles for article (PubMed ID: 2423691)
1. Inhibition of cyclic nucleotide phosphodiesterases from pig coronary artery by benzo-separated analogues of 3-isobutyl-1-methylxanthine.
Schneller SW; Ibay AC; Martinson EA; Wells JN
J Med Chem; 1986 Jun; 29(6):972-8. PubMed ID: 2423691
[TBL] [Abstract][Full Text] [Related]
2. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
3. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
4. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
Wynne DG; Poole-Wilson PA; Harding SE
Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, induces cytodifferentiation of follicular granulosa cells cultured in serum-free medium.
Weinberger-Ohana P; Goldschmit D; Mizrachi L; Orly J
Endocrinology; 1984 Dec; 115(6):2160-9. PubMed ID: 6209121
[TBL] [Abstract][Full Text] [Related]
7. Effects of the cyclic nucleotide phosphodiesterase inhibitors, rolipram, 3-isobutyl-1-methylxanthine, amrinone and zaprinast, on pancreatic exocrine secretion in dogs.
Iwatsuki K; Horiuchi A; Ren LM; Chiba S
Eur J Pharmacol; 1991 Dec; 209(1-2):63-8. PubMed ID: 1726088
[TBL] [Abstract][Full Text] [Related]
8. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
Lerner U; Ransjö M; Fredholm BB
Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of cyclic nucleotide phosphodiesterase from the rod outer segments of the frog retina by 3-hydroxypyridine].
Polianskiĭ NB; Smirnov LD; Shvedova AA; Kagan VE
Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (1):27-31. PubMed ID: 6199045
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3-isobutylxanthine.
Garst JE; Kramer GL; Wu YJ; Wells JN
J Med Chem; 1976 Apr; 19(4):499-503. PubMed ID: 177782
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
Weston MC; Anderson N; Peachell PT
Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
[TBL] [Abstract][Full Text] [Related]
13. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
Choi OH; Shamim MT; Padgett WL; Daly JW
Life Sci; 1988; 43(5):387-98. PubMed ID: 2456442
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 2',3'-cyclic nucleotide 3'-phosphodiesterase activity from bovine, human and guinea pig brain.
Sprinkle TJ; Knerr JR
Brain Res; 1981 Jun; 214(2):455-9. PubMed ID: 6263423
[TBL] [Abstract][Full Text] [Related]
15. The stimulatory effects of caffeine, theophylline, lysine-theophylline and 3-isobutyl-1-methylxanthine on human sperm motility.
Jiang CS; Kilfeather SA; Pearson RM; Turner P
Br J Clin Pharmacol; 1984 Aug; 18(2):258-62. PubMed ID: 6207849
[TBL] [Abstract][Full Text] [Related]
16. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
Wilke R; Arch JR; Nicholson CD
Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
Rabe KF; Tenor H; Dent G; Schudt C; Liebig S; Magnussen H
Am J Physiol; 1993 May; 264(5 Pt 1):L458-64. PubMed ID: 7684572
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini.
Gardner JD; Sutliff VE; Walker MD; Jensen RT
Am J Physiol; 1983 Nov; 245(5 Pt 1):G676-80. PubMed ID: 6195928
[TBL] [Abstract][Full Text] [Related]
19. Isoprenaline-like effects of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine on mechanical, biochemical and electrophysiological parameters in the mammalian heart.
Brückner R; Gramann S; Nose M; Schmitz W; Scholz H
Experientia; 1985 Jun; 41(6):732-4. PubMed ID: 2408914
[TBL] [Abstract][Full Text] [Related]
20. Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.
Sircar I; Weishaar RE; Kobylarz D; Moos WH; Bristol JA
J Med Chem; 1987 Nov; 30(11):1955-62. PubMed ID: 2822926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
